Lyophilization market forecast to double in size by 2020
03 December 2014
The global market for lyophilization equipment, used to freeze-dry drug compounds so they are dehydrated for easier transportation, is expected to double in value to $4.8 billion from $2.7 billion by 2020, according to a new report.
The top 10 FierceMedicalDevices news stories in 2014
02 December 2014
Transformational scientific leaps forward that fulfill fundamental patient needs have fueled the appetite for biotech in recent years. But this year, perhaps for the first time, visions for major med tech leaps forward with the integration of information and wireless technologies seemed to be everywhere. This offers a lot of tantalizing possibilities and readers were eager to explore them.
The top 10 FierceBiotech stories of 2014
02 December 2014
Last year at this time, the daily reports we produce in the life sciences group were opened about 93,000 times per day, on average. Now, that opener number has swelled to 125,000 with a group of subscribers that exceeds 270,000, and web traffic is reliably more than one million visits per month. In October, we hit 1.3 million.
Russian government predicts bright prospects to national pharma industry
26 November 2014
The Russian pharmaceutical industry is booming, despite the economic recession in the country and devaluation of national currency, caused by sanctions, according to Sergey Tsyb, Russia’s Deputy Minister of Industry and Trade.
Top 10 Drugmakers in Emerging Markets
26 November 2014
It seemed like a match made in heaven. A few years ago, as the patent cliff neared and drugmakers were looking for new sources of revenue, market researchers were toting up growth prospects around the world. The answer, for both, was emerging markets. Drug spending would more or less stagnate in mature markets such as the United States and the European Union. But in the developing world, drug spending was just taking off.
Researchers develop 'Wi-Fi'-triggered dissolvable, implantable device for drug delivery
26 November 2014
Researchers at Tufts University have come up with a resorbable electronic implant that when used in mice was able to be triggered remotely by wireless signal and deliver heat to infected tissue.
FDA to stop regulating some medical device software
26 November 2014
FDA will exercise "enforcement discretion" in its regulation (or lack thereof) of medical device data systems by opting not to enforce the general controls, such as product registration and Quality System Regulation, that normally apply to Class I devices, the agency said in a June 20 draft guidance.
NIH scientists determine how environment contributes to several human diseases
26 November 2014
Using a new imaging technique, National Institutes of Health researchers have found that the biological machinery that builds DNA can insert molecules into the DNA strand that are damaged as a result of environmental exposures. These damaged molecules trigger cell death that produces some human diseases, according to the researchers.
How To Build Real Patient-Centered Pharmaceutical Companies
26 November 2014
With such a focus these days on buzzwords such as "patient-centric," "patient-centered," and "patient-centricity," some people are predicting “patient engagement” to be the next big movement in our industry, much as blockbuster drugs were a decade or more ago. But while improving patient engagement sounds fairly straightforward for those who directly interact with patients (e.g., doctors, nurses, nurse practitioners, and physicians assistants), for the biopharmaceutical industry, successfully executing this concept has been — and continues to be — much more challenging.
IMS: Global Spending on Medicines to Rise 30% by 2018
25 November 2014
Global spending on medicines will skyrocket by as much as 30% over the next five years, increasing to $1.3 trillion in 2018, according to a new forecast from the IMS Institute for Healthcare Informatics. The higher levels of growth in drug spending will be due to the waning impact of patent expiries, increased access to medicine worldwide, and the introduction of new specialty medications.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024